# Thymoglobulin (ATG) Dose Finding Study

> **NCT00409695** · PHASE1,PHASE2 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 1 (actual)

## Conditions studied

- Graft vs Host Disease

## Interventions

- **DRUG:** Low Dose Thymoglobulin (ATG)
- **DRUG:** High Dose Thymoglobulin (ATG)

## Key facts

- **NCT ID:** NCT00409695
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-12
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Lack of Accrual
- **Last updated:** 2012-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00409695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00409695, "Thymoglobulin (ATG) Dose Finding Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00409695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*